ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627745 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627745; 2) Community: the network communities that were significantly associated with the response to NSC 627745; 3) Molecule: the relationships between components within communities and NSC 627745; 4) MDR: the compounds that were significantly associated with the NSC 627745.

NSC Compound Enrichment Correlation
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0382675857669587 0.1749307
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0382675857669587 0.75144095
NSC 380721 Eremantholide B 0.0382675857669587 0.5864316
NSC 3852 8-Quinolinol, 5-nitroso- (8CI9CI) 0.0382675857669587 0.38583242
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.0382675857669587 0.47380284
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0382675857669587 0.27399706
NSC 621335 Null 0.0382675857669587 0.19949965
NSC 621336 Null 0.0382675857669587 0.6456973
NSC 624771 5H-Benzocyclohepten-5-one, 4-(acetyloxy)-6,6-dibromo- 6,7,8,9-tetrahydro- 0.0382675857669587 0.6880102
NSC 132483 Aminopterin Derivative 0.0388857481216096 0.28234174
Total:131  Current:114    [First] [Prev] [Next] [Last]